Mesonephric-like adenocarcinoma of the uterine corpus: Comprehensive analyses of clinicopathological, molecular, and prognostic characteristics with retrospective …
…, YS Kim, GH Han, HS Kim, K Na - Cancer Genomics & …, 2022 - cgp.iiarjournals.org
Background/Aim: Uterine mesonephric-like adenocarcinoma (MLA) is a rare malignant tumor
of the female genital tract. Patients and Methods: We reviewed 237 endometrial carcinoma …
of the female genital tract. Patients and Methods: We reviewed 237 endometrial carcinoma …
[HTML][HTML] Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body
K Na, HS Kim - The American Journal of Surgical Pathology, 2019 - journals.lww.com
Mesonephric adenocarcinoma (MNAC) is a rare tumor of the female genital tract mainly
occurring in the uterine cervix. To date, only a few cases of MNAC arising from of the uterine …
occurring in the uterine cervix. To date, only a few cases of MNAC arising from of the uterine …
CTNNB1 mutations in ovarian microcystic stromal tumors: identification of a novel deletion mutation and the use of pyrosequencing to identify reported point mutation
K Na, EK Kim, W Jang, HS Kim - Anticancer Research, 2017 - ar.iiarjournals.org
Background/Aim: Microcystic stromal tumor (MCST) is a rare stromal tumor of the ovary. In this
study, we describe clinicopathological characteristics and results of mutational analyses of …
study, we describe clinicopathological characteristics and results of mutational analyses of …
[HTML][HTML] External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo …
JY Lee, YS Chung, K Na, HM Kim, CK Park… - Journal of …, 2017 - ncbi.nlm.nih.gov
Objective The chemotherapy response score (CRS) system based on histopathological
examination has been recently proposed for tubo-ovarian high-grade serous carcinoma (HGSC) …
examination has been recently proposed for tubo-ovarian high-grade serous carcinoma (HGSC) …
Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases
Purpose The TruSight Tumor 170 (TST-170) panel consists of a DNA workflow for the
identification of single-nucleotide variants, small insertions and deletions, and copy number …
identification of single-nucleotide variants, small insertions and deletions, and copy number …
Malignant transformation of WHO grade I meningiomas after surgery or radiosurgery: systematic review and meta-analysis of observational studies
S Nakasu, A Notsu, K Na… - Neuro-oncology advances, 2020 - academic.oup.com
Background The incidence and clinical features of the malignant transformation of benign
meningiomas are poorly understood. This study examined the risk of the malignant …
meningiomas are poorly understood. This study examined the risk of the malignant …
Glioblastomas harboring gene fusions detected by next-generation sequencing
HY Woo, K Na, J Yoo, JH Chang, YN Park… - Brain tumor …, 2020 - Springer
Oncogenic gene fusions have been reported in diffuse gliomas and may serve as potential
therapeutic targets. Here, using next-generation sequencing analysis (Illumina TruSight …
therapeutic targets. Here, using next-generation sequencing analysis (Illumina TruSight …
[HTML][HTML] Mesonephric-like adenocarcinoma of the uterine corpus: Comprehensive immunohistochemical analyses using markers for mesonephric, endometrioid and …
H Kim, K Na, GE Bae, HS Kim - Diagnostics, 2021 - mdpi.com
Mesonephric-like adenocarcinoma (MLA) of the uterine corpus is a rare but distinct malignant
tumor of the female genital tract, demonstrating a characteristic morphology and unique …
tumor of the female genital tract, demonstrating a characteristic morphology and unique …
Dedifferentiated mesonephric-like adenocarcinoma of the uterine corpus
S Choi, K Na, SW Kim, HS Kim - Anticancer research, 2021 - ar.iiarjournals.org
Background/Aim: We present a case of uterine dedifferentiated mesonephric-like adenocarcinoma
(MLA). Case Report: A 54-year-old woman underwent total hysterectomy for a uterine …
(MLA). Case Report: A 54-year-old woman underwent total hysterectomy for a uterine …
TP53 mutation status of tubo-ovarian and peritoneal high-grade serous carcinoma with a wild-type p53 immunostaining pattern
K Na, JY Sung, HS Kim - Anticancer research, 2017 - ar.iiarjournals.org
Background/Aim: Diffuse and strong nuclear p53 immunoreactivity and a complete lack of p53
expression are regarded as indicative of missense and nonsense mutations, respectively, …
expression are regarded as indicative of missense and nonsense mutations, respectively, …